UNICEF Supply Division is responsible for procuring vaccines and devices for countries on behalf of GAVI Alliance, a broad partnership of public and private organizations managed by the GAVI Secretariat - Swiss Foundation, and directed by a Board of stakeholders. The GAVI Board approves country programmes based on a set of specific criteria: From 2011 each country must have a gross national product per capita less than $1,500 (as per World Bank data); a current routine coverage of diphtheria/tetanus/pertussis (DTP3) vaccine greater than 70 per cent; a functioning Inter-Agency Co-ordinating Committee; a comprehensive multi-year immunization plan.
In 2011, UNICEF procured on behalf of GAVI 247 million doses of vaccine, to value of $663 million, delivered to 66 countries, as well as 163 million pieces of safe injection supplies, to a value of $8.8 million.
Since the launch in June 2009 of the first Advance Market Commitment (AMC), piloted for pneumococcal vaccines, UNICEF has undertaken two procurement rounds and a third round is to be initiated in August 2012. A total of 96 million doses of pneumococcal vaccines have been contracted, to be supplied on an annual basis from 2014. Some 16 countries have to date introduced the vaccine with support from GAVI within 18 months from first product approvals, and an additional 10 countries are expected to introduce before the end of 2012. The AMC is an innovative financing mechanism which allows access to pneumococcal vaccines for children in GAVI supported countries at the same time as the vaccines are being introduced in developed countries. Please click here for details.
In 2012, UNICEF also entered into the first long term supply arrangements with two suppliers for rotavirus vaccine to be delivered 2012 to 2016. The first GAVI supported country to procure through UNICEF introduced rotavirus in 2011, and an additional 8 countries are anticipated to introduce the vaccine during 2012.
More about GAVI (this link opens in a new window and will take you to a non-UNICEF website):